Ascentage Pharma announced six clinical studies selected for ASCO 2026, including three rapid oral presentations featuring Olverembatinib, Lisaftoclax, and Alrizomadlin for various cancer treatments.
Ascentage Pharma announced six clinical studies selected for 2026 ASCO Annual Meeting, including three rapid oral presentations featuring Olverembatinib, Lisaftoclax, and Alrizomadlin across oncology indications.
Insilico Medicine Forms Industry's First Longevity Board
Insilico Medicine established the industry's first Longevity Board, led by Eli Lilly's Andrew Adams, to oversee AI-driven aging research and drug discovery targeting biological aging processes and healthspan extension.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 25 of 529
Get full access to view complete information
Frequently Asked Questions Regarding 香港交易所
Company Overview
2000
Founded
Financial Services
Industry
Hong Kong
Location
21,789
Ranking
10,100 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding 香港交易所
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.